Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880044 · ClinicalTrials.gov registry record · NA
Detection of Barrett s Esophagus in Patients Without GERD Symptoms
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT04880044: Completed NA study, sponsored by Case Comprehensive Cancer Center.
NCT04880044 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 132 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04880044, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a method to detect Barrett's esophagus (BE) in individuals with a new office-based diagnostic test.
Primary Outcome
PPV of EC/EG in a non-GERD population that has three or more non-GERD risk factors for BE. Participants who are at risk will be offered EC/EG. Those who are positive will undergo subsequent EGD PPV = (EC/EG positive \& EGD positive) / ((EC/EG positive \& EGD positive) + (EC/EG positive \& EGD negative))
Interventions
- DIAGNOSTIC_TEST EsoCheck/EsoGuard (EC/EG)
- DIAGNOSTIC_TEST Esophago-gastro-duodenoscopy (EGD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2022-01-05 |
| Est. Completion | 2025-02-25 |
| Phase | NA |
What the finished NCT04880044 record still lists
NCT04880044 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which EsoCheck/EsoGuard (EC/EG) is the first listed.
NCT04880044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04880044 about?
NCT04880044 is a clinical study titled "Detection of Barrett s Esophagus in Patients Without GERD Symptoms". The purpose of this study is to develop a method to detect Barrett's esophagus (BE) in individuals with a new office-based diagnostic test.
What is the current status of trial NCT04880044?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2022-01-05. Estimated completion is 2025-02-25.
What interventions are being tested in trial NCT04880044?
The interventions under investigation include: EsoCheck/EsoGuard (EC/EG) (DIAGNOSTIC_TEST), Esophago-gastro-duodenoscopy (EGD) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04880044?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04880044's enrollment target sits among peer trials
132 729th of 2000 higher than 1,269 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI